🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 3, randomized, double-blind, active comparator-controlled s...
Status
Completed
Location
Central Research Associates ( Site 0067)
Start Date
2022-07-13
Trial ID
NCT05425732
This Phase 1 and Phase 2 study will evaluate the safety, tolerability and i...
Status
Completed
Location
Simon Williamson Clinic ( Site 0004)
Start Date
2019-12-06
Trial ID
NCT04168190
Treatments Being Tested
The purpose of this study is to compare the safety, tolerability, and immun...
Status
Completed
Location
Souseikai PS Clinic ( Site 0201)
Start Date
2021-02-04
Trial ID
NCT04665050
Treatments Being Tested
This is a phase 3, randomized, double-blind, active comparator-controlled s...
Status
Completed
Location
Fundacion Estudios Clinicos ( Site 0200)
Start Date
2022-11-07
Trial ID
NCT05569954
The primary objectives of this study are to evaluate the safety and tolerab...
Status
Completed
Location
Aventiv Research ( Site 0022)
Start Date
2023-02-13
Trial ID
NCT05696080
This study will evaluate the safety, tolerability, and immunogenicity of a ...
Status
Completed
Location
Pueblo Family Physicians ( Site 0014)
Start Date
2022-07-13
Trial ID
NCT05393037
Treatments Being Tested
This a study of V116 in adults ≥50 years of age who concomitantly received ...
Status
Completed
Location
Central Phoenix Medical Clinic-Synexus Clinical Research US ( Site 0012)
Start Date
2022-09-23
Trial ID
NCT05526716
Treatments Being Tested
This a study of V116 in adults ≥50 years of age who previously received a p...
Status
Completed
Location
Central Research Associates ( Site 0024)
Start Date
2022-07-12
Trial ID
NCT05420961
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Central Research Associates ( Site 0145)
Start Date
2024-01-18
Trial ID
NCT06177912
This is a phase 3, randomized, double-blind, active comparator-controlled s...
Status
Completed
Location
Medical Corporation Heishinkai OPHAC Hospital ( Site 1008)
Start Date
2023-01-10
Trial ID
NCT05633992